B

BeOne

Global oncology therapeutics discovery, development, manufacturing

Head of Global Strategic Feasibility and Study Start-Up - Global Strategic Feasibility and Study Start Up

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • Experience with study optimization vendors, tools, and methods.
  • Experience managing processes and timelines associated with Study Start-Up documentation, including informed consent development, lab manual creation, and investigator brochures.
  • Demonstrated process improvement experience, including mapping processes, measuring components, and delivering standardization and efficiency.
  • Proven experience in data analysis and interpretation to inform decision-making.
  • Expertise in principles driving country and site identification, feasibility, and study startup strategies.
  • Demonstrated experience managing, influencing, building relationships with, and achieving results with senior partners in an environment with competing priorities.
  • Strong understanding of clinical study operations, feasibility assessment, and global clinical development processes.
  • Proven ability to lead and inspire teams, and experience managing cross-functional teams and working in a matrix environment.
  • Demonstrated strategic thinking and informed decision-making based on feasibility assessments and business objectives.
  • Proficiency with Microsoft Office Suite, CTMS applications, EDC applications, analytic tools such as Citeline and Studytrove, and additional feasibility software.
  • Bachelor’s degree or higher in a scientific, medical, or healthcare discipline.
  • For a BA or BS, 12 or more years of experience in feasibility, clinical study management, personnel management, and operations management; for an MA or MS, 8 or more years of experience. Prior experience in a leadership capacity is essential.

Responsibilities

  • Oversee global strategic feasibility proposals for global clinical studies in alignment with corporate objectives, therapeutic areas, and regional requirements.
  • Ensure global standardization of data documentation, data assets, tools, and processes to support quality decision-making at therapeutic area, indication, program, and study levels.
  • Drive process optimization initiatives to enhance feasibility assessment methodologies, tools, and metrics for efficiency, quality, and scalability.
  • Collaborate with internal stakeholders, including Clinical Operations, Clinical Development, Medical Affairs, Regulatory Affairs, and Biostatistics, to align and provide strategic input for study design and execution.
  • Establish and maintain partnerships with external organizations, including vendors, investigative sites, and key opinion leaders, to enhance study feasibility and optimize resources.
  • Build, lead, and mentor a high-performing team of feasibility and study start-up professionals.
  • Identify potential risks and challenges in study feasibility and develop mitigation strategies to minimize their impact on timelines, budget, and study success.
  • Prepare and present feasibility process and tool development progress, metrics, and recommendations to senior management and key stakeholders.
  • Participate in global projects representing Global Clinical Operations and the Global Strategic Feasibility team to support BeOne R&D goals.
  • Line-manage global strategic feasibility team members and drive ownership and accountability within the team and with external stakeholders.

Desired Qualifications

  • Knowledge of multiple therapeutic areas is highly desirable.
  • An advanced degree, such as an MSc, PhD, or MBA, is preferred.

About the Company

BeOne

Global oncology therapeutics discovery, development, manufacturing

BeOne Medicines discovers, develops, and commercializes oncology therapies worldwide, focusing on hematologic cancers and solid tumors. Its products work by leveraging internal R&D and clinical development to bring therapies to market quickly, with Brukinsa serving as a leading backbone in the US and European markets. It differentiates itself through a large-scale global clinical network and cost-efficient development and manufacturing that support high margins and a focus on large-market cancer indications. Its goal is to expand access to high-impact, affordable cancer treatments across more than 45 countries while growing its pipeline into immunology and solid tumors.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dongcheng District, China
Founded
2010

Recently Posted Jobs

Explore more opportunities at BeOne

See more jobs